AUTL News and Press, Autolus Therapeutics plc From 11/08/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chinese education stocks are moving higher on Monday as reports claim China will allow them to resume their work. Source: MIA Studio / Shutterstock.com Many Chinese education stocks took a beating earlier this year...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Autolus Therapeutics (NASDAQ: AUTL ) stock is surging higher in trading Monday following news of a major investment in the clinical-stage biopharmaceutical company. Source: Isabelle OHara / Shutterstock.com Ac...

Shares of Autolus Therapeutics plc (NASDAQ: AUTL) jumped about 30% in premarket trading on Monday after it said Blackstone Life Sciences agreed to invest up to $250 million to fund the development of its new therapy for Leukemia. Blackstone is taking a sizable equity stake in Autolu...

Pioneer Power Solutions (NASDAQ:PPSI) +46% launches E-Boost - smart, mobile EV charging solutions Autolus Therapeutics (NASDAQ:AUTL)+26% on securing $250M strategic funding from Blackstone The Trade Desk (NASDAQ:TTD) +23% on Q3 earnings. Volta(NYSE:VLTA) +19%. Gaotu Techedu (NYSE:GO...

Read the full story here: For further details see: Wall Street Breakfast: Gasoline Prices Are Going Up (Podcast)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re starting off the week with a dive into the biggest pre-market stock movers for Monday. Source: Eric Urquhart/Shutterstock.com New out of China concerning after-school tutoring has ...

– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country – Durability and favorable toxicity profile of obe-cel supports its potential as the first stand-alone ther...

- Demonstrates progress on the Company’s commercial manufacturing process and builds on positive obe-cel clinical data presented at EHA Conference Call and Webcast to be held Tuesday, December 14, 2021 at 8:00 am ET / 1:00 pm GMT LONDON, Nov. 04, 2021 (GLOBE NE...

Autolus Therapeutics plc (AUTL) Q3 2021 Earnings Conference Call November 3, 2021 08:30 AM ET Company Participants Dr. Lucinda Crabtree - Vice President of Business Planning and Strategy Dr. Christian Itin - Chief Executive Officer Christopher Vann - Chief Operating Officer Andrew Oakley - Ch...

Autolus Therapeutics (NASDAQ:AUTL): Q3 GAAP EPS of -$0.47 beats by $0.04. Revenue of $0.24M (-64.7% Y/Y) misses by $0.01M. Press Release For further details see: Autolus Therapeutics EPS beats by $0.04, misses on revenue